ODX.L Regulatory News (ODX)

Omega Diagnostics Group PLC

("Omega" or the "Company")

Distributor Agreement

10 April 2013

Omega (AIM:ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, is pleased to announce it has agreed to amend the Terms of its existing licence agreement with Immunodiagnostic Systems Holdings plc (IDS) allowing the Company to appoint IDS as its exclusive distributor in certain territories for allergy tests to be run on the automated IDS-iSYS platform. The countries covered by the agreement are those countries where IDS already has a direct presence, namely, the USA, Germany, France, the Nordic regions and the UK.

It is envisaged that the Company and IDS will enter into a distribution agreement in due course which will provide IDS customers with an increased menu of tests on the IDS-iSYS platform and will allow Omega to reduce its time to market in the selected countries. The Company is still developing an initial launch panel of 40+ allergy tests with a planned launch date in the final quarter of the new financial year ending 31 March 2014.

Contacts:

Omega Diagnostics Group PLC Tel: 01259 763 030

Andrew Shepherd, Chief Executive www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director

Jag Grewal, Group Sales and Marketing Director

finnCap Ltd Tel: 020 7220 0500

Geoff Nash/Christopher Raggett (Corporate Finance)

Stephen Norcross/Mia Gardner (Corporate Broking)

Walbrook PR Limited Tel: 020 7933 8780

Paul McManus Mob: 07980 541 893; paul.mcmanus@wallbrookpr.com

Lianne Cawthorne Mob: 07584 391 303; lianne.cawthorne@walbrookpr.com